Together, these results demonstrate that ALK1 signaling inhibition increased the expression of key R point mediators, including CDK4, CDK6, and CDK2 to promote p-RB1 elevation in vascular lesions of HHT mice and HHT patient skin biopsies. This evidence concerns the gene CDK4 and hereditary hemorrhagic telangiectasia.